West Pharmaceutical Services (WST) Interest Expenses (2009 - 2026)

West Pharmaceutical Services has disclosed Interest Expenses across 18 years of filings, most recently posting $1.9 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $1.9 million, up 375.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 11.11% YoY), and the FY2025 annual result was $500000.0, down 83.33% from the prior year.
• Interest Expenses came in at $1.9 million for Q1 2026 at West Pharmaceutical Services, up from -$200000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.9 million in Q3 2023 to a low of -$800000.0 in Q4 2024.
• The 5-year median for Interest Expenses is $1.6 million (2024), against an average of $1.3 million.
• Across the five-year window, Interest Expenses tumbled 166.67% in 2024 and surged 375.0% in 2026, its largest moves.
• West Pharmaceutical Services' Interest Expenses stood at $1.7 million in 2022, then decreased by 29.41% to $1.2 million in 2023, then plunged by 166.67% to -$800000.0 in 2024, then surged by 75.0% to -$200000.0 in 2025, then soared by 1050.0% to $1.9 million in 2026.
• The last three Interest Expenses figures came in at $1.9 million (Q1 2026), -$200000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.